International comparisons of survival from lung cancer: pitfalls and warnings
Sara C Erridge*, Henrik Møller, Allan Price and David Brewster
Correspondence *University of Edinburgh, Edinburgh Cancer Centre, Crewe Road South, Edinburgh EH4 2XU, UK
Email serridge@staffmail.ed.ac.uk
Population-based survival data can provide valuable comparative data on outcome but should be interpreted with caution. Ideally, data from the whole population, including clinical-only diagnoses, should be reported and the methods of case identification described. Erridge et al. highlight the need for methods of data collection and comparison to be as similar as possible, and for important factors related to the patient, tumor characteristics and treatment that might impact outcome to be reported.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.